Real-time enrollment status for this neoplasia clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:30 PM UTC
| NCT Number | NCT01577251 |
| Recruiting Status | Recruiting |
| Condition | Neoplasia |
| Phase | Clinical Trial |
| Target Enrollment | 8,000 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | March 4, 2026 (Mar 4, 2026) |
As of July 16, 2026: Clinical trial NCT01577251 is currently recruiting participants. This clinical trial study for neoplasia is actively seeking new participants at 4 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01577251 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01577251 was last updated Mar 4, 2026 (March 4, 2026). HelloStudys verifies this status automatically.